OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

GMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genmab A/S ADS (GMAB) Earnings Date & Reports

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GMAB is expected to report earnings to rise 32.36% to 40 cents per share on August 07

Genmab A/S ADS GMAB Stock Earnings Reports

Q2'25

Est.

$0.40

Q1'25

Beat

by $0.09

Q4'24

Beat

by $0.49

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.01

The last earnings report on May 08 showed earnings per share of 30 cents, beating the estimate of 21 cents. With 680.21K shares outstanding, the current market capitalization sits at 13.52B.

View a ticker or compare two or three

Compare

GMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GMAB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for GMAB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Carl Jacobsens Vej 30

Phone

+45 70202728

Employees

2204

Web

https://www.genmab.com